---
title: "Levothyroxine - Myxedema"
sidebar: mydoc_sidebar
permalink: db00451-mesh-d009230-1.html
toc: false 
---


Path ID: `DB00451_MESH_D009230_1`
{% include image.html url="images/db00451-mesh-d009230-1.png" file="db00451-mesh-d009230-1.png" alt="db00451-mesh-d009230-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D013974">MESH:D013974 </a> | Levothyroxine | Drug |
| <a href="https://identifiers.org/MESH:D014284">MESH:D014284 </a> | Triiodothyronine | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P10827">UniProt:P10827 </a> | Thyroid hormone receptor alpha | Protein |
| <a href="https://identifiers.org/UniProt:P10828">UniProt:P10828 </a> | Thyroid hormone receptor beta | Protein |
| <a href="https://identifiers.org/GO:0002154">GO:0002154 </a> | Thyroid hormone mediated signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/GO:0070460">GO:0070460 </a> | Thyroid-stimulating hormone secretion | BiologicalProcess |
| <a href="https://identifiers.org/CHEBI:18085">CHEBI:18085 </a> | Glycosaminoglycan | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0000969">HP:0000969 </a> | Edema | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D009230">MESH:D009230 </a> | Myxedema | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Levothyroxine | HAS METABOLITE | Triiodothyronine |
| Triiodothyronine | INCREASES ACTIVITY OF | Thyroid Hormone Receptor Alpha |
| Triiodothyronine | INCREASES ACTIVITY OF | Thyroid Hormone Receptor Beta |
| Thyroid Hormone Receptor Alpha | POSITIVELY REGULATES | Thyroid Hormone Mediated Signaling Pathway |
| Thyroid Hormone Receptor Beta | POSITIVELY REGULATES | Thyroid Hormone Mediated Signaling Pathway |
| Thyroid Hormone Mediated Signaling Pathway | NEGATIVELY REGULATES | Thyroid-Stimulating Hormone Secretion |
| Thyroid-Stimulating Hormone Secretion | INCREASES ABUNDANCE OF | Glycosaminoglycan |
| Glycosaminoglycan | POSITIVELY CORRELATED WITH | Edema |
| Edema | MANIFESTATION OF | Myxedema |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Myxedema](https://en.wikipedia.org/wiki/Myxedema)
  - [https://go.drugbank.com/drugs/DB00451](https://go.drugbank.com/drugs/DB00451)
